Publicaciones en las que colabora con ESTEBAN JESUS MORCILLO SANCHEZ (20)

2012

  1. Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guidelines in a Spanish Tertiary Hospital

    Journal of Clinical Pharmacology, Vol. 52, Núm. 7, pp. 1106-1114

  2. Piclamilast inhibits the pro-apoptotic and anti-proliferative responses of A549 cells exposed to H 2O 2 via mechanisms involving AP-1 activation

    Free Radical Research, Vol. 46, Núm. 5, pp. 690-699

2011

  1. Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 118, Núm. 5, pp. 615-623

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2009

  1. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan

    Journal of Immunology, Vol. 183, Núm. 2, pp. 1393-1402

  2. Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis

    European Journal of Pharmacology, Vol. 609, Núm. 1-3, pp. 132-139

2003

  1. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats

    British Journal of Pharmacology, Vol. 138, Núm. 6, pp. 1037-1048

  2. Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen

    European Respiratory Journal, Vol. 21, Núm. 3, pp. 394-400

2001

  1. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats

    European Respiratory Journal, Vol. 17, Núm. 6, pp. 1228-1235

2000

  1. Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils

    Inflammation Research, Vol. 49, Núm. 11, pp. 600-609

  2. β-adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 4, pp. 410-417

1999

  1. Contraction of human airways by oxidative stress protection by N- acetylcysteine

    Free Radical Biology and Medicine, Vol. 27, Núm. 3-4, pp. 392-400

  2. Oxidative stress and pulmonary inflammation: Pharmacological intervention with antioxidants

    Pharmacological Research, Vol. 40, Núm. 5, pp. 393-404

1997

  1. Bronchodilator and anti-inflammatory activities of SCA40: Studies in human isolated bronchus, human eosinophils, and in the guinea-pig in vivo

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 356, Núm. 6, pp. 806-814

1993

  1. Effect of Glutathione on Canine Myocardial Ischaemia Without Reperfusion

    Journal of Pharmacy and Pharmacology, Vol. 45, Núm. 4, pp. 298-302

1991

  1. Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 343, Núm. 5, pp. 505-510

1988

  1. Limitation of myocardial infarct size by N-acetylcysteine in dogs

    Medical Science Research, Vol. 16, Núm. 1, pp. 41-42

1986

  1. Beneficial effects of N-acetyl cysteine on acute myocardial infarction in open-chest dogs

    Archivos de Farmacologia y Toxicologia, Vol. 12, Núm. 1, pp. 37-40

1983

  1. Effects of antiinflammatory drugs in a model of acute transmural infarction in the dog

    Journal de Pharmacologie, Vol. 14, Núm. 3, pp. 283-293

1981

  1. Differential effects of anti-inflammatory agents on canine acute myocardial infarction

    IRCS Medical Science, Vol. 9, Núm. 7, pp. 574-575